Abstract
Cytochrome P450 (CYP) 7B1 is involved in many metabolic processes including androgen metabolism. Genetic variation in the CYP7B1 gene may play a role in predisposition to prostate cancer. Here, we screened the human CYP7B1 gene for possible polymorphisms. Only one single polymorphism was detected, a C–G change in the promoter –104 base pair from the transcription start site. The allele frequency was investigated in Swedish men and compared to a Korean population, as it is known that the frequency of prostate cancer is low among Orientals. We found that the frequency of the G-allele was 4.04% in Swedes (n=150) but only 0.33% among Koreans (n=153). Computer analysis indicated that the two variants bind with different affinities to a CCAAT-box binding protein. Expression studies with reporter constructs showed significantly higher transcriptional activity of the G variant in Hek293 cells (2.7-fold, P<0.05). In conclusion, we report here for the first time the detection of a single polymorphism in the CYP7B1 gene. This polymorphism is associated with phenotypic differences in an expression system and a widely different allele frequency in two ethnic populations, with great differences in the incidence of prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001; 229: 432–442.
Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001; 98: 6330–6335.
Weihua Z, Lathe R, Warner M, Gustafsson JA . An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 2002; 99: 13589–13594.
Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res 2002; 62: 1784–1789.
Devgan SA, Henderson BE, Yu MC, Shi CY, Pike MC, Ross RK et al. Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk. Prostate 1997; 33: 9–12.
Chiang JYL . Regulation of bile acid synthesis. Front Biosci 1998; 3: D176–93.
Martin KO, Budai K, Javitt N . B, Cholesterol and 27-hydroxycholesterol 7 alpha-hydroxylation: evidence for two different enzymes. J Lipid Res 1993; 34: 581–588.
Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, Bjorkhem I et al. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J Biol Chem 1996; 271: 18024–18031.
Wu Z, Martin KO, Javitt NB, Chiang JY . Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J Lipid Res 1999; 40: 2195–2203.
Setchell KD, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998; 102: 1690–1703.
Wu Z, Chiang JY . Transcriptional regulation of human oxysterol 7 alpha-hydroxylase gene (CYP7B1) by Sp1. Gene 2001; 272: 191–197.
Quandt K, Frech K, Karas H, Wingender E, Werner T . MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878–4884.
Kurioka H, Kishi H, Isshiki H, Tagoh H, Mori K, Kitagawa T et al. Isolation and characterization of a TATA-less promoter for the human RAG-1 gene. Mol Immunol 1996; 33: 1059–1066.
Ramji DP, Foka P . CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002; 365(Part 3): 561–575.
Tetlow N, Liu D, Board P . Polymorphism of human Alpha class glutathione transferases. Pharmacogenetics 2001; 11: 609–617.
Brown AJ, Jessup W . Oxysterols and atherosclerosis. Atherosclerosis 1999; 142: 1–28.
Cheon J, Kim CS, Lee ES, Hong SJ, Cho YH, Shin EC et al. Survey of incidence of urological cancer in South Korea: a 15-year summary. Int J Urol 2002; 9: 445–454.
Hsing AW, Reichardt JK, Stanczyk FZ . Hormones and prostate cancer: current perspectives and future directions. Prostate 2002; 52: 213–235.
Board PG, Chelvanayagam G, Jermiin LS, Tetlow N, Tzeng HF, Anders MW et al. Identification of novel glutathione transferases and polymorphic variants by expressed sequence tag database analysis. Drug Metab Dispos 2001; 29(Part 2): 544–547.
Forsberg L, de Faire U, Morgenstern R . Low yield of polymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum Mutat 1999; 13: 294–300.
Soderstrom T, Wadelius M, Andersson SO, Johansson JE, Johansson S, Granath F et al. 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer. Pharmacogenetics 2002; 12: 307–312.
Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E . Prostate cancer associated with CYP17 genotype. Pharmacogenetics 1999; 9: 635–639.
Wadelius M, Autrup JL, Stubbins MJ, Andersson SO, Johansson JE, Wadelius C et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999; 9: 333–340.
Roh HK, Dahl ML, Johansson I, Ingelman-Sundberg M, Cha YN, L . Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population. Pharmacogenetics 1996; 6: 441–447.
Roh HK, Dahl ML, Tybring G, Yamada H, Cha YN, Bertilsson L . CYP2C19 genotype and phenotype determined by omeprazole in a Korean population. Pharmacogenetics 1996; 6: 547–551.
Livak KJ . Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14: 143–149.
Acknowledgements
This work was supported by grants from the Swedish Cancer Society, the World Anti-Doping Agency (WADA) and the Swedish Foundation for Strategic Research. Professor Ralf Morgenstern, Institute of Environmental Medicine, Karolinska Institute kindly provided HepG2 cells and Dr Mary Hunt, Department of Clinical Chemistry, Karolinska Institute kindly provided HEK293 cells.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jakobsson, J., Karypidis, H., Johansson, JE. et al. A functional C–G polymorphism in the CYP7B1 promoter region and its different distribution in Orientals and Caucasians. Pharmacogenomics J 4, 245–250 (2004). https://doi.org/10.1038/sj.tpj.6500236
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500236
Keywords
This article is cited by
-
Unravelling genetic variants of a swedish family with high risk of prostate cancer
Hereditary Cancer in Clinical Practice (2022)
-
A novel polymorphism in the 17β-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men
The Pharmacogenomics Journal (2007)